Search information pages
About Pediatric Rheumatology
This page includes information about the aims and scope of Pediatric Rheumatology, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.
Aims & scope
Pediatric Rheumatology, the official publication of the Pediatric Rheumatology European Society (PReS) is an open access, peer-reviewed, online journal encompassing all aspects of clinical and basic research related to pediatric rheumatology and allied subjects.
Pediatric rheumatology is a pediatric subspecialty for evaluation and treatment of non-surgical musculoskeletal syndromes and diseases in children and adolescents, particularly autoimmune and rheumatic diseases.
Pediatric Rheumatology began publishing as Pediatric Rheumatology Online Journal in 2003. For access to articles published prior to 2006, contact the Editorial team.
The journal’s scope of diseases and syndromes include musculoskeletal pain syndromes, rheumatic fever and post-streptococcal syndromes, juvenile idiopathic arthritis, systemic lupus erythematosus, juvenile dermatomyositis, local and systemic scleroderma, Kawasaki disease, Henoch-Schonlein purpura and other vasculitides, sarcoidosis, inherited musculoskeletal syndromes, autoinflammatory syndromes, and others. Pediatric Rheumatology encourages submissions on educational advances, drug studies, laboratory and radiological evaluations, and outcome measures.
PReS are providing financial support to aid any authors who require assistance with the article processing charge (APC). Applicable authors would be charged a discounted article processing charge of £350 payable for articles accepted for publication.
Authors who would like to apply for the reduced APC should contact the contact the Editorial team. Applicable authors can request this support during the submission process, stating payment via the PReS Shared Support option.
All articles published by Pediatric Rheumatology are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
Authors of articles published in Pediatric Rheumatology are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.
For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. Pediatric Rheumatology therefore levies an article-processing charge of £1170/$1960/€1410 for each article accepted for publication. If the submitting author's institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
All articles published in Pediatric Rheumatology are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in Pediatric Rheumatology include:
- Current contents
- Google Scholar
- Index Copernicus
- PubMed Central
- Science Citation Index Expanded
The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including e-Depot (The Netherlands).
The full text of all research articles published by BioMed Central is also available on SpringerLink.
Pediatric Rheumatology is tracked by Thomson Reuters (ISI) and has an Impact Factor of 1.47.
Publication and peer review process
Criteria for publication
Pediatric Rheumatology considers the following types of articles:
- Research: reports of data from original research.
- Review: comprehensive, authoritative, descriptions of any subject within the scope of the journal. These articles are also written by opinion leaders that have been invited by the Editorial Board.
- Commentary: short, focused and opinionated articles on any subject within the scope of the journal. These articles are usually related to a contemporary issue, such as recent research findings, and are often written by opinion leaders.
- Hypothesis: short articles presenting an untested original hypothesis backed solely by previously published results rather than any new evidence.
- Short report: brief reports of data from original research.
- Case report: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction. Please note that only those case report articles of exceptional interest will be considered for publication in the journal.
Contributors to Pediatric Rheumatology benefit from fast and professional peer review. After an initial screening for general suitability, the Editors will assign submissions for external peer review. The journal will operate a 'closed' peer-review policy, and will aim to reach a first decision within six weeks.
Edited by Charles Spencer and Alberto Martini Pediatric Rheumatology is supported by an expert Editorial Board.
Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Pediatric Rheumatology, a personalized section of the site.
High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.
Pediatric Rheumatology will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.
All manuscripts submitted to Pediatric Rheumatology should adhere to BioMed Central's editorial policies.
Citing articles in Pediatric Rheumatology
Articles in Pediatric Rheumatology should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Pediatr Rheumatol [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Pediatr Rheumatol 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Why publish your article in Pediatric Rheumatology?
Pediatric Rheumatology's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.
Speed of publication
Pediatric Rheumatology offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Pediatric Rheumatology, BioMed Central and PubMed Central and will also be included in PubMed.
Online publication in Pediatric Rheumatology gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Pediatric Rheumatology are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Pediatric Rheumatology's pages and on the BioMed Central homepage.
In addition, articles published in Pediatric Rheumatology may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Pediatric Rheumatology. A list of articles recently press-released by journals published by BioMed Central is available here.
Authors of articles published in Pediatric Rheumatology retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright and license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.